Omeros (OMER) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -2.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.60% |
| Dec 31, 2025 | 27.12% |
| Sep 30, 2025 | -84.26% |
| Jun 30, 2025 | -34.99% |
| Mar 31, 2025 | 26.19% |
| Dec 31, 2024 | -72.80% |
| Sep 30, 2024 | 51.61% |
| Jun 30, 2024 | -57.15% |
| Mar 31, 2024 | -52.98% |
| Dec 31, 2023 | -30.56% |
| Sep 30, 2023 | 7.94% |
| Jun 30, 2023 | 36.41% |
| Mar 31, 2023 | -55.77% |
| Dec 31, 2022 | -185.56% |
| Sep 30, 2022 | 199.83% |
| Jun 30, 2022 | 327.40% |
| Mar 31, 2022 | -270.42% |
| Dec 31, 2021 | 212.04% |
| Sep 30, 2021 | -280.46% |
| Jun 30, 2021 | 29.44% |
| Mar 31, 2021 | 12.58% |
| Dec 31, 2020 | -86.29% |
| Sep 30, 2020 | 116.14% |
| Jun 30, 2020 | -64.48% |
| Mar 31, 2020 | 84.52% |
| Dec 31, 2019 | 10.56% |
| Sep 30, 2019 | -5.12% |
| Jun 30, 2019 | -26.39% |
| Mar 31, 2019 | -67.14% |
| Dec 31, 2018 | 59.05% |
| Sep 30, 2018 | 63.41% |
| Jun 30, 2018 | 14.79% |
| Mar 31, 2018 | -59.12% |
| Dec 31, 2017 | 99.83% |
| Sep 30, 2017 | -44.45% |
| Jun 30, 2017 | 29.63% |
| Mar 31, 2017 | -4.86% |
| Dec 31, 2016 | -231.71% |
| Sep 30, 2016 | 129.48% |
| Jun 30, 2016 | 102.48% |
| Mar 31, 2016 | -17.43% |
| Dec 31, 2015 | 18.43% |
| Sep 30, 2015 | 31.91% |
| Jun 30, 2015 | 28.41% |
| Mar 31, 2015 | -56.04% |
| Dec 31, 2014 | 23.46% |
| Sep 30, 2014 | -45.40% |
| Jun 30, 2014 | 59.51% |
| Mar 31, 2014 | -48.44% |
| Dec 31, 2013 | -21.41% |
| Sep 30, 2013 | -94.44% |